Brendan Delaney

Brendan Delaney

Former President and Chief Executive OfficeratWhitehawk Therapeutics· In proxies 2022–2023

Pay in FY2023+7% from the year before · Whitehawk Therapeutics stock -84.3% the same year

Brendan Delaney was paid $1.6M in FY2023 (Dec), up 7%. Whitehawk Therapeutics stock fell 84.3% that year.

Pay$100 in the stock at the end of FY21 → $8
Pay is from the Summary Compensation Table of each Whitehawk Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Whitehawk TherapeuticsPublic company · 4 yr
    • Former President and Chief Executive Officer2022 – Present · 4 yrStock in role -86%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?